Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04726371 · ClinicalTrials.gov registry record · NA
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 415
- Enrollment target
NCT04726371: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04726371 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 415 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04726371, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 415 participants
- Enrollment target
Study Summary
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings is a research study aimed at developing, implementing, and evaluating a package of interventions specifically designed to reduce COVID-19 and other infectious-disease incidence, hospitalizations, and mortality among staff and adults with Serious Mental Illness and Intellectual and Developmental Disabilities in congregate-living settings.
Interventions
- BEHAVIORAL Generic Best Practices
- BEHAVIORAL Tailored Best Practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 415 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04726371
The ClinicalTrials.gov registry entry for NCT04726371 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 415 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Generic Best Practices is the first listed.
NCT04726371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04726371 about?
NCT04726371 is a clinical study titled "Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings". Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings is a research study aimed at developing, implementing, and evaluating a package of interventions specifically designed to reduce COVID-19 and other ...
What is the current status of trial NCT04726371?
This trial is currently completed. It is a NA study. The enrollment target is 415 participants. The study started on 2020-11-01. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04726371?
The interventions under investigation include: Generic Best Practices (BEHAVIORAL), Tailored Best Practices (BEHAVIORAL).
Who is sponsoring clinical trial NCT04726371?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.